6VWW
Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2.
Summary for 6VWW
Entry DOI | 10.2210/pdb6vww/pdb |
Descriptor | Uridylate-specific endoribonuclease, GLYCEROL, MAGNESIUM ION, ... (6 entities in total) |
Functional Keywords | sars corona virus, endonuclease, structural genomics, center for structural genomics of infectious diseases, csgid, viral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) |
Total number of polymer chains | 2 |
Total formula weight | 84383.24 |
Authors | Kim, Y.,Jedrzejczak, R.,Maltseva, N.,Endres, M.,Godzik, A.,Michalska, K.,Joachimiak, A.,Center for Structural Genomics of Infectious Diseases (CSGID) (deposition date: 2020-02-20, release date: 2020-03-04, Last modification date: 2023-10-11) |
Primary citation | Kim, Y.,Jedrzejczak, R.,Maltseva, N.I.,Wilamowski, M.,Endres, M.,Godzik, A.,Michalska, K.,Joachimiak, A. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. Protein Sci., 29:1596-1605, 2020 Cited by PubMed Abstract: Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is rapidly spreading around the world. There is no existing vaccine or proven drug to prevent infections and stop virus proliferation. Although this virus is similar to human and animal SARS-CoVs and Middle East Respiratory Syndrome coronavirus (MERS-CoVs), the detailed information about SARS-CoV-2 proteins structures and functions is urgently needed to rapidly develop effective vaccines, antibodies, and antivirals. We applied high-throughput protein production and structure determination pipeline at the Center for Structural Genomics of Infectious Diseases to produce SARS-CoV-2 proteins and structures. Here we report two high-resolution crystal structures of endoribonuclease Nsp15/NendoU. We compare these structures with previously reported homologs from SARS and MERS coronaviruses. PubMed: 32304108DOI: 10.1002/pro.3873 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report